Skip to content

Comparing Fluoride Varnish and Sealant to Prevent White Spots in Orthodontic Patients

THE EFFICACY OF MI VARNISH VERSUS PRO SEAL SEALANT ON PREVENTION OF WHITE SPOT LESIONS IN ORTHODONTIC PATIENTS: A RANDOMIZED CLINICAL TRIAL

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04560478
Enrollment
40
Registered
2020-09-23
Start date
2018-10-01
Completion date
2020-03-01
Last updated
2020-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

White Spot Lesion

Keywords

Oral Hygiene, Orthodontics, White spot lesion, enamel decalcification

Brief summary

The purpose of the study is o compare the efficacy of CPP-ACP MI Varnish and ProSeal sealant in preventing white spot lesion (WSL) formation in orthodontic patients.

Detailed description

This prospective randomized clinical trial included 40 orthodontic patients between the ages of 12-17 who were randomly allocated to two groups. Group 1 (Sealant Group) received sealant on the maxillary anterior canines, lateral incisors, and central incisors, with reapplication of the sealant every 3 months. Group 2 (Varnish Group) had MI Varnish applied every 4-6 weeks, without sealant placed on the maxillary anterior teeth. White spot lesion formation was evaluated with standardized digital photographs at two timepoints, T1 (initial appointment before bonding), and T2 (12 months later, with brackets removed). The brackets were removed in order to facilitate an adequate photographic exam. Photographs were analyzed side-by-side at the conclusion of the study with the Enamel Decalcification Index (EDI). The location of WSLs were recorded by tooth type and by region. Oral hygiene was evaluated at T1 and T2.

Interventions

DEVICEPro Seal Sealant

Sealant was reapplied every 3 months

Fluoride varnish was applied every 4-6 weeks

Sponsors

Texas A&M University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

single center, parallel, randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* no significant medical history * no underlying medical problems such as Sjogren's Syndrome or conditions requiring more than 2 medications (to prevent bias of possible dry mouth) * less than 17 years old at the start of orthodontic treatment, * fully erupted permanent maxillary canines and incisors, starting fixed orthodontic treatment * ability to come to appointments every 4-6 weeks.

Exclusion criteria

* professional fluoride application in the last 3 months * allergy to milk * untreated cavitated lesions * heavy initial fluorosis * dry mouth * pregnancy * any illness/condition that the investigators felt would affect the study outcome.

Design outcomes

Primary

MeasureTime frameDescription
Enamel Decalcification Index12 monthsExtent and severity of white spot lesion formation

Secondary

MeasureTime frameDescription
Location of White Spot Lesions12 monthsMesial, Distal, Incisal or Gingival Region
Most Common Tooth for White Spot Formation12 MonthsMaxillary Canine, Lateral, or Central Incisor
Oral Hygiene Status12 MonthsMeasurement of plaque accumulation on maxillary teeth
Sex Differences12 MonthsMale versus Female

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026